Recombinant Xenopus tropicalis MARVEL domain-containing protein 2 (marveld2)

What is MARVEL domain-containing protein 2 (Marveld2) in Xenopus tropicalis?

Marveld2 is a protein found in Xenopus tropicalis (Western clawed frog) that belongs to the MARVEL (MAL and Related proteins for VEsicle trafficking and membrane Link) domain-containing family. It is a full-length protein consisting of 568 amino acids encoded by the marveld2 gene (UniProt ID: Q0IHQ3). The protein contains characteristic transmembrane regions that form part of the MARVEL domain structure . Xenopus tropicalis serves as an excellent model organism for studying marveld2 function due to its diploid genome that shows high synteny with the human genome, making it valuable for comparative studies of human disease states .

How can recombinant Xenopus tropicalis Marveld2 protein be expressed and purified?

Recombinant Xenopus tropicalis Marveld2 protein can be efficiently expressed and purified using the following methodological approach:

• Expression system selection: E. coli serves as an effective heterologous expression system for producing recombinant Marveld2 .

• Vector construction: The full-length coding sequence (1-568aa) should be cloned into an expression vector containing an N-terminal His-tag for purification purposes.

• Expression conditions:

  • Transform the construct into an appropriate E. coli strain

  • Induce protein expression under optimized conditions (temperature, IPTG concentration, duration)

  • Harvest cells by centrifugation

• Purification protocol:

  • Lyse cells using appropriate buffer systems

  • Perform affinity chromatography using Ni-NTA or similar matrix to capture His-tagged protein

  • Elute with imidazole gradient

  • Perform SDS-PAGE analysis to confirm purity (>90% purity can be achieved)

• Post-purification processing:

  • Dialyze against appropriate buffer

  • Lyophilize to powder form for long-term storage

What are the optimal storage conditions for recombinant Xenopus tropicalis Marveld2?

For maximum stability and activity retention of recombinant Xenopus tropicalis Marveld2, the following storage protocols are recommended:

• Short-term storage (up to one week):

  • Store working aliquots at 4°C

  • Avoid repeated freeze-thaw cycles which can cause protein degradation

• Long-term storage:

  • Store lyophilized powder at -20°C/-80°C upon receipt

  • Aliquoting is necessary for multiple use

  • Reconstituted protein should be stored with glycerol

• Reconstitution protocol:

  • Briefly centrifuge vial prior to opening

  • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Add 5-50% glycerol (final concentration recommended: 50%)

  • Aliquot for long-term storage at -20°C/-80°C

• Storage buffer composition:

  • Tris/PBS-based buffer

  • 6% Trehalose

  • pH 8.0

What experimental approaches can be used to study Marveld2 function in Xenopus tropicalis?

Several experimental approaches can be employed to elucidate Marveld2 function in Xenopus tropicalis:

• Genome editing techniques:

  • CRISPR/Cas9 and TALEN systems are highly effective in Xenopus tropicalis for generating gene knockouts

  • These techniques allow for mosaic disruption of marveld2, enabling the generation of loss-of-function models

• Expression analysis:

  • RT-PCR for temporal expression patterns

  • In situ hybridization for spatial expression patterns

  • Immunohistochemistry using specific antibodies against Marveld2

• Functional assays:

  • Embryo microinjection of mRNA or morpholinos

  • Transgenic reporter approaches for promoter analysis

  • Co-immunoprecipitation for protein interaction studies

• Phenotypic analysis:

  • Morphological examination of embryos and tadpoles

  • Histological assessment of affected tissues

  • Behavioral assays to assess functional deficits

These approaches take advantage of Xenopus tropicalis' external embryo development and transparent tadpoles, which facilitate experimental manipulation and post-analysis of animals .

How can Marveld2 mutations be effectively analyzed in Xenopus tropicalis?

Analysis of Marveld2 mutations in Xenopus tropicalis requires a comprehensive approach combining genetic, molecular, and phenotypic assessments:

• Mutation generation:

  • CRISPR/Cas9 targeting specific sites in the marveld2 gene

  • Design sgRNAs targeting conserved domains or specific functional regions

• Genotyping strategies:

  • DNA extraction from tadpole tail clips

  • PCR amplification of targeted regions

  • Sequencing analysis to confirm mutations

  • T7 endonuclease I assay or heteroduplex mobility assay for rapid screening

• Molecular confirmation:

  • Design primers for targeted regions (e.g., forward primer: 5′-CACCTGATCTTCTTCCTC-3′, reverse primer: 5′-GGGAAATCAGCTTATCTTAT-3′ for amplifying mutation sites)

  • Sanger sequencing to verify specific mutations

  • RT-PCR to assess transcript levels and potential splicing effects

• Bioinformatic analysis:

  • Use predictive tools (SIFT, PolyPhen, MutationTaster, FATHMM, CADD, Varsome) to assess potential impact of mutations

  • Compare with known human mutations in homologous regions

This systematic approach allows researchers to thoroughly characterize marveld2 mutations and their functional consequences in Xenopus tropicalis.

What role does Marveld2 play in developing Xenopus tropicalis tissues?

Marveld2 plays critical roles in developing Xenopus tropicalis tissues, particularly in epithelial barrier formation and sensory system development:

• Epithelial barriers:

  • Contributes to tight junction formation in epithelial cells

  • Regulates paracellular permeability in various epithelial tissues

  • Affects epithelial integrity during organ morphogenesis

• Auditory system development:

  • Evidence from human studies indicates marveld2 mutations can cause hearing loss, suggesting a conserved role in auditory system development

  • Likely involved in maintaining ion homeostasis in the inner ear

• Developmental timeline:

  • Expression begins during gastrulation

  • Increases during neurulation and organogenesis

  • Becomes restricted to specific epithelial tissues in later development

• Tissue distribution:

  • Primarily expressed in epithelial tissues with tight junctions

  • Particularly important in sensory epithelia

  • Also found in developing neural tissues

The transparency of Xenopus tadpoles makes this model particularly valuable for studying the spatiotemporal expression patterns and developmental functions of Marveld2 .

How can Xenopus tropicalis Marveld2 serve as a model for human MARVELD2-related disorders?

Xenopus tropicalis Marveld2 offers a sophisticated model for studying human MARVELD2-related disorders due to several key advantages:

• Genetic conservation:

  • High synteny between Xenopus tropicalis and human genomes

  • Conservation of functional domains between species

  • Similar exon-intron organization facilitating the study of splicing mutations

• Disease modeling approach:

  • Introduction of specific mutations identified in human patients with MARVELD2-related disorders

  • For example, the c.1331+1G>A mutation associated with nonsyndromic hearing loss can be replicated

  • Mosaic genome editing allows generation of highly penetrant and low latency disease models

• Phenotypic analysis pipeline:

  • Histological examination of affected tissues

  • Immunohistochemical evaluation to assess protein localization

  • Functional assays to measure epithelial barrier integrity

  • Behavioral tests to assess auditory function

• Comparative analysis with human data:

  • Correlation between genotype and phenotype across species

  • Validation of pathogenic mechanisms in a vertebrate model

This approach provides a versatile platform for understanding molecular mechanisms underlying MARVELD2-related human disorders and testing potential therapeutic interventions .

What are the challenges and solutions in analyzing splice site mutations in Xenopus tropicalis Marveld2?

Analyzing splice site mutations in Xenopus tropicalis Marveld2 presents several challenges that require specialized methodological approaches:

• Challenges in splice mutation analysis:

  • Accurately predicting effects on mRNA processing

  • Determining the ratio of correctly vs. incorrectly spliced transcripts

  • Assessing tissue-specific splicing effects

  • Correlating splicing alterations with phenotypic outcomes

• Methodological solutions:

  • RNA extraction protocols:

    • Use TRIzol or similar reagents for high-quality RNA isolation

    • Extract RNA from specific tissues to detect tissue-specific effects

    • Implement rapid extraction to minimize RNA degradation

  • Transcript analysis techniques:

    • RT-PCR with primers spanning exon junctions

    • Quantitative RT-PCR to measure relative abundance of transcript variants

    • Next-generation sequencing for comprehensive transcriptome analysis

    • Minigene assays to validate specific splicing alterations

• Case study approach:

  • The c.1331+1G>A mutation in MARVELD2 affects a splice donor site

  • Similar mutations can be introduced in Xenopus tropicalis using CRISPR/Cas9

  • Analysis would include:

    • Extraction of RNA from relevant tissues

    • RT-PCR with primers flanking the affected exon

    • Sequencing of RT-PCR products to identify aberrant splice products

    • Quantification of normal vs. aberrant transcripts

• Validation strategies:

  • Western blot analysis to confirm protein size alterations

  • Immunofluorescence to assess protein localization

  • Functional assays to determine the impact on tight junction formation

This systematic approach allows researchers to thoroughly characterize the molecular consequences of splice site mutations in Xenopus tropicalis Marveld2 and their functional impacts.

How can high-throughput approaches be optimized for studying Marveld2 protein interactions in Xenopus tropicalis?

High-throughput approaches for studying Marveld2 protein interactions in Xenopus tropicalis require specialized optimization strategies:

• Protein-protein interaction screening:

  • Yeast two-hybrid system optimization:

    • Use the full-length or domain-specific constructs of Marveld2

    • Screen against Xenopus tropicalis cDNA libraries from relevant tissues

    • Validate interactions with co-immunoprecipitation

  • Affinity purification-mass spectrometry (AP-MS):

    • Express His-tagged Marveld2 in Xenopus tissues or cell lines

    • Optimize purification conditions using Tris/PBS-based buffers

    • Analyze interacting partners by MS/MS

    • Classify interactions based on cellular compartments and functions

• CRISPR-based interaction screens:

  • Generate a library of sgRNAs targeting potential interactors

  • Introduce these into Marveld2-reporter Xenopus tropicalis embryos

  • Identify genetic interactions based on altered reporter expression

  • Validate top hits with individual knockouts

• Interactome analysis pipeline:

  • Bioinformatic prediction of interaction networks

  • Experimental validation of key interactions

  • Functional classification of interacting partners

  • Cross-species comparison with human MARVELD2 interactome

• Membrane protein interaction considerations:

  • Optimize detergents for membrane protein extraction (e.g., n-dodecyl-β-D-maltoside)

  • Use proximity labeling approaches (BioID, APEX) for transient interactions

  • Implement split-GFP systems for in vivo interaction validation

This comprehensive approach enables researchers to decipher the complex interaction network of Marveld2 in Xenopus tropicalis, providing insights into its molecular functions and potential roles in disease processes.

What are the most effective genomic engineering strategies for studying Marveld2 function in Xenopus tropicalis?

Advanced genomic engineering approaches offer powerful tools for dissecting Marveld2 function in Xenopus tropicalis:

• CRISPR/Cas9 optimization strategies:

  • Knockout approach:

    • Design sgRNAs targeting early exons or conserved domains

    • Implement multiplexed sgRNA delivery for increased efficiency

    • Use Cas9 nickase approach to reduce off-target effects

    • Optimize microinjection parameters (concentration, timing, location)

  • Knock-in approach:

    • Design specific homology-directed repair templates

    • Introduce reporter genes or epitope tags for tracking expression

    • Create point mutations mimicking human disease variants

    • Implement conditional alleles for temporal control

• Tissue-specific manipulation:

  • Use tissue-specific promoters to drive Cas9 expression

  • Implement inducible CRISPR systems for temporal control

  • Target mosaic genome editing to specific tissues or developmental stages

• Phenotypic analysis pipeline:

  • Histological examination to assess tissue architecture

  • Immunohistochemical evaluation for protein localization

  • Functional assays to measure epithelial barrier integrity

  • Behavioral tests to assess sensory functions

• Comparative genomic approach:

  • Analyze conservation of regulatory elements across species

  • Identify conserved binding sites for transcription factors

  • Compare phenotypes with other model organisms and human data

Table: Genomic Engineering Approaches for Marveld2 Analysis

These genomic engineering strategies, combined with the unique advantages of Xenopus tropicalis as a model organism, provide powerful tools for understanding Marveld2 function in development and disease .

What emerging technologies will advance Marveld2 research in Xenopus tropicalis?

Several cutting-edge technologies are poised to revolutionize Marveld2 research in Xenopus tropicalis:

• Single-cell transcriptomics and proteomics:

  • Mapping Marveld2 expression at single-cell resolution

  • Identifying cell type-specific interaction partners

  • Characterizing the effects of Marveld2 mutations on global gene expression

• Advanced imaging techniques:

  • Super-resolution microscopy for detailed protein localization

  • Live imaging in transparent tadpoles

  • Correlative light and electron microscopy to visualize tight junction ultrastructure

• Organ-on-chip and ex vivo culture systems:

  • Maintaining Xenopus tropicalis tissue explants with controlled manipulation

  • Studying barrier function in epithelial monolayers

  • Testing pharmacological modulators of Marveld2 function

• Comparative multi-omics approaches:

  • Integration of genomic, transcriptomic, and proteomic data

  • Cross-species comparison between Xenopus, zebrafish, and human data

  • Systems biology modeling of tight junction assembly and function

These emerging technologies will provide unprecedented insights into Marveld2 biology and its implications for human health and disease .

How can Xenopus tropicalis Marveld2 research contribute to therapeutic development?

Research on Xenopus tropicalis Marveld2 has significant potential to inform therapeutic development for human disorders:

• Drug discovery applications:

  • Screening compounds that modulate tight junction assembly or function

  • Identifying molecules that can rescue specific Marveld2 mutations

  • Testing gene therapy approaches using Xenopus tropicalis models

• Translational research pipeline:

  • Validating pathogenic mechanisms of human MARVELD2 mutations

  • Establishing phenotype-genotype correlations for clinical prediction

  • Developing biomarkers for MARVELD2-related disorders

• Precision medicine approaches:

  • Testing mutation-specific therapies in Xenopus models

  • Evaluating personalized treatment strategies

  • Developing combinatorial approaches targeting multiple pathway components

• Interdisciplinary collaborations:

  • Combining expertise in developmental biology, genetics, and clinical research

  • Leveraging high-throughput screening capabilities

  • Integrating computational modeling with experimental validation